Factitious increase in thyrotropin in a neonate caused by a maternally transmitted interfering substance [5]

Clinical Chemistry

Volumn 52, Issue 3, 2006, Pages 541-542

  Newman, Julie D ^a   Bergman, Philip B ^a,b   Doery, James C G ^a,b   Balazs, Nicholas D H ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

CASE REPORT; CONGENITAL HYPOTHYROIDISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LETTER; MALE; NEWBORN; NEWBORN SCREENING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; PREGNANCY; THYROTROPIN;

EID: 33644540779     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.064832     Document Type: Letter

References (15)

1. Connelly JF, Coakley JC, Gold H, Francis I, Mathur KS, Rickards AL, et al. Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 1: the screening programme, demography, baseline perinatal data, and diagnostic classification. J Pediatr Endocrinol Metab 2001;14:1597-610.
2. Connelly JF, Rickards AL, Coakley JC, Price GJ, Francis I, Mathur KS, et al. Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 2: treatment, progress, and outcome. J Pediatr Endocrinol Metab 2001;14:1611-34.
3. Kim WJ, Laterza OF, Hock KG, Pierson-Perry JF, Kaminiski DM, Medguich M, et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem 2002;48:1028-34.
4. Weber TH, Kapyaho KI, Tanner P. Endogenous interference in immunoassays in clinical chemistry: a review. Scand J Clin Lab Invest 1990;50(Suppl 201):77-82.
5. Kricka U. Interference in immunoassays-still a threat. Clin Chem 2000;46:1037-8.
6. Selby C. Interference in immunoassay. Ann Clin Biochem 1999;36:704-21.
7. Ward G, McKinnon L, Badrick T, Hickman PE. Heterophilic antibodies remain a problem for the immunoassay laboratory. Am J Clin Pathol 1997;108:417-21.
8. Ismail AAA, Barth JH. Wrong biochemistry results. BMJ 2001;323:705-6.
9. Ismail AAA, Walker PL, Barth JH, Lewandowski KC, Jones R, Burr W. Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotrophin immunoassay results. Clin Chem 2002;48:2023-9.
10. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem 2002;48:2008-16.
11. Gendrel D, Feinstein MC, Grenier J, Roger M, Ingrand J, Chaussin JL, et al. Falsely elevated serum thyrotropin (TSH) in newborn infants: transfer from mothers to infants of a factor interfering in the TSH radioimmunoassay. J Clin Endocrinol Metab 1981;52:62-5.
12. la. Leino A, Kaihola HL, Kleimola V, Kero P. False pathological thyrotropin (TSH) level in mother and infant caused by interfering antibodies in the TSH radioimmunoassay. Acta Paediatr Scand 1985;74:607-8.
13. Czernichow P, Vandalem JL, Hennen G. Transient neonatal hyperthyrotropinaemia: a factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mothers. J Clin Endocrinol Metab 1981;53:387-93.
14. Larsson A, Hedenborg, G, Carlstrom A. Placental transfer of maternal anti-rabbit IgG causing falsely elevated TSH levels in neonates. Acta Paediatr Scand 1981;70:699-703.
15. Jospe N, Berkovitz GD, Corcoran LE, Humphrey RL. Factitious transient neonatal hyperthyrotropinemia. J Endocrinol Invest 1988;11:129-32.